Outcome Analysis in Epilepsy Patients Undergoing Switchover from Levetiracetam to Brivaracetam
Background and Aim: Epilepsy is a chronic noncommunicable disorder causing repeated seizures, which are characterized by abnormal electrical discharges in the brain. There are various pharmacotherapeutic classes of drugs that can be used to treat this disorder. This study aims to compare two such dr...
Saved in:
| Main Authors: | Agna Maria Rejy, Ananya S Prasad, Anju Susan Babu, Abijith P Biju, R. Lakshmi, P. A. Daisy, A. V. Sreeram Prasad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Archives of Medicine and Health Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/amhs.amhs_196_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative analysis of brivaracetam and levetiracetam in epilepsy treatment
by: Ming-Yuan Hsu, et al.
Published: (2025-01-01) -
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study
by: Simona Lattanzi, et al.
Published: (2025-03-01) -
The Effect of Treatment for Epilepsy Associated with Malignant Neoplasms of the Brain: a Literature Review
by: Y. Wang, et al.
Published: (2023-12-01) -
Brivaracetam and rufinamide combination increased seizure threshold and improved neurobehavioral deficits in corneal kindling model of epilepsy
by: Awais Sattar, et al.
Published: (2025-02-01) -
Increase of Brivaracetam serum concentration with introduction of Cenobamate
by: Lena Bender, et al.
Published: (2025-04-01)